Enteroblastic and Hepatoid Colorectal Carcinomas are Aggressive Cancers With a Distinctive Immunophenotype, While Clear Cell Carcinoma Appears to Represent Clear Cell Change in Conventional Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Enteroblastic and Hepatoid Colorectal Carcinomas are Aggressive Cancers With a Distinctive Immunophenotype, While Clear Cell Carcinoma Appears to Represent Clear Cell Change in Conventional Colorectal Cancer.
Authors: Khan F; Department of Pathology, Lehigh Valley Health Network/Health Network Laboratories, Allentown., Polydorides AD; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai., Paulsen JD; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai., Chen W; Department of Pathology, The Ohio State University, Columbus., Vazzano J; Department of Pathology, The Ohio State University, Columbus., Huber A; Department of Pathology, University of Rochester Medical Center, Rochester, NY., Papke D Jr; Department of Pathology, Brigham and Women's Hospital., Sharifai N; Department of Pathology, University of Maryland, Baltimore, MD., Stashek K; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Ruz-Caracuel I; Department of Pathology, Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, Spain., Allende D; Department of Pathology, Cleveland Clinic, Cleveland, OH., McHugh K; Department of Pathology, Mayo Clinic Arizona, Scottsdale, AZ., Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York., Longacre TA; Department of Pathology, Stanford University, Stanford., Dhall D; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL., Makhoul E; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL., Lee MJ; Department of Pathology, Columbia University., Collins K; Department of Pathology, University of Indiana, Indianapolis, IA., Ulbright TM; Department of Pathology, University of Indiana, Indianapolis, IA., Zhang ML; Department of Pathology, Massachusetts General Hospital, Boston, MA., Westerhoff M; Department of Pathology, University of Michigan, Ann Arbor, MI., Gao ZH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver., Matsukuma K; Department of Pathology, University of California Davis, Sacramento., Choi WT; Department of Pathology, University of California San Francisco, San Francisco, CA., Kakar S; Department of Pathology, University of California San Francisco, San Francisco, CA., Chetty R; Diagnexia, Dublin, Ireland., Nowak K; Department of Pathology, University of Toronto, Toronto, Canada., Serra S; Department of Pathology, University of Toronto, Toronto, Canada., Zhang X; Department of Pathology, Yale University, New Haven, CT., Chen W; Department of Pathology, Duke University, Durham, NC., Gonzalez RS; Department of Pathology, Emory University School of Medicine, Atlanta, GA.
Source: The American journal of surgical pathology [Am J Surg Pathol] 2026 Aug 01; Vol. 50 (8), pp. 883-893. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-0979
DOI:10.1097/PAS.0000000000002555